Home LiteratureArticle Details
PMID: 18504305 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Membrane traffic and turnover in TRP-ML1-deficient cells: a revised model for mucolipidosis type IV pathogenesis.

The Journal of experimental medicine ·Vol. 205 ·No. 6 ·2008-06-09 ·Pages 1477-90

Miedel MT, Rbaibi Y, Guerriero CJ, Colletti G, Weixel KM, Weisz OA, Kiselyov K

Abstract

The lysosomal storage disorder mucolipidosis type IV (MLIV) is caused by mutations in the transient receptor potential-mucolipin-1 (TRP-ML1) ion channel. The "biogenesis" model for MLIV pathogenesis suggests that TRP-ML1 modulates postendocytic delivery to lysosomes by regulating interactions between late endosomes and lysosomes. This model is based on observed lipid trafficking delays in MLIV patient fibroblasts. Because membrane traffic aberrations may be secondary to lipid buildup in chronically TRP-ML1-deficient cells, we depleted TRP-ML1 in HeLa cells using small interfering RNA and examined the effects on cell morphology and postendocytic traffic. TRP-ML1 knockdown induced gradual accumulation of membranous inclusions and, thus, represents a good model in which to examine the direct effects of acute TRP-ML1 deficiency on membrane traffic. Ratiometric imaging revealed decreased lysosomal pH in TRP-ML1-deficient cells, suggesting a disruption in lysosomal function. Nevertheless, we found no effect of TRP-ML1 knockdown on the kinetics of protein or lipid delivery to lysosomes. In contrast, by comparing degradation kinetics of low density lipoprotein constituents, we confirmed a selective defect in cholesterol but not apolipoprotein B hydrolysis in MLIV fibroblasts. We hypothesize that the effects of TRP-ML1 loss on hydrolytic activity have a cumulative effect on lysosome function, resulting in a lag between TRP-ML1 loss and full manifestation of MLIV.

MeSH Terms
Acyltransferases/deficiency,genetics Cell Membrane/physiology Endocytosis HeLa Cells Humans Hydrogen-Ion Concentration Kinetics Lipids/physiology Lysosomes/enzymology,physiology Models, Biological Mucolipidoses/enzymology,genetics RNA, Small Interfering/genetics Transfection
Chemicals
Lipids RNA, Small Interfering Acyltransferases malonyl-CoA-D-tryptophan N-malonyltransferase
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Miedel Mark T
Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Rbaibi Youssef
Guerriero Christopher J
Colletti Grace
Weixel Kelly M
Weisz Ora A
Kiselyov Kirill
References (54)
54 references, click to expand
  1. Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog.
    Nat Genet. 2001 May;28(1):64-8 PMID: 11326278
  2. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel.
    Hum Mol Genet. 2000 Oct 12;9(17):2471-8 PMID: 11030752
  3. Mucolipidosis type IV.
    Mol Genet Metab. 2001 Jul;73(3):197-203 PMID: 11461186
  4. Basis of lethality in C. elegans lacking CUP-5, the Mucolipidosis Type IV orthologue.
    Dev Biol. 2006 May 15;293(2):382-91 PMID: 16530747
  5. Constitutive achlorhydria in mucolipidosis type IV.
    Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1207-12 PMID: 9448310
  6. Identification of the gene causing mucolipidosis type IV.
    Nat Genet. 2000 Sep;26(1):118-23 PMID: 10973263
  7. TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage.
    J Biol Chem. 2005 Dec 30;280(52):43218-23 PMID: 16257972
  8. Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes.
    Am J Hum Genet. 1999 Sep;65(3):773-8 PMID: 10441585
  9. CUPpling calcium to lysosomal biogenesis.
    Trends Cell Biol. 2004 Sep;14(9):471-3 PMID: 15350973
  10. Cultured skin fibroblasts derived from patients with mucolipidosis 4 are auto-fluorescent.
    Pediatr Res. 1995 Jun;37(6):687-92 PMID: 7651750
  11. G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts.
    Neurochem Res. 1999 Apr;24(4):475-9 PMID: 10227679
  12. TRPML and lysosomal function.
    Biochim Biophys Acta. 2007 Aug;1772(8):851-8 PMID: 17306511
  13. Phosphatidylcholine storage in mucolipidosis IV.
    Clin Chim Acta. 1989 May 15;181(2):167-74 PMID: 2736780
  14. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease.
    Proc Natl Acad Sci U S A. 1998 May 26;95(11):6373-8 PMID: 9600972
  15. Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases.
    Philos Trans R Soc Lond B Biol Sci. 2003 May 29;358(1433):885-91 PMID: 12803922
  16. Two di-leucine motifs regulate trafficking of mucolipin-1 to lysosomes.
    Traffic. 2006 Mar;7(3):337-53 PMID: 16497227
  17. Lysosomal trafficking functions of mucolipin-1 in murine macrophages.
    BMC Cell Biol. 2007 Dec 21;8:54 PMID: 18154673
  18. Metabolic fate of oleic acid derived from lysosomal degradation of cholesteryl oleate in human fibroblasts.
    J Lipid Res. 1996 Nov;37(11):2271-9 PMID: 8978478
  19. Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV.
    Biochem Biophys Res Commun. 2004 Oct 1;322(4):1384-91 PMID: 15336987
  20. Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic.
    Traffic. 2006 Oct;7(10):1388-98 PMID: 16978393
  21. Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis.
    Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4483-8 PMID: 15070744
  22. [14C]Methylamine accumulation in cultured human skin fibroblasts--a biochemical test for lysosomal storage and lysosomal diseases.
    Clin Chim Acta. 1994 Jun;227(1-2):121-33 PMID: 7955409
  23. Genetic analysis of endocytosis in Caenorhabditis elegans: coelomocyte uptake defective mutants.
    Genetics. 2001 Sep;159(1):133-45 PMID: 11560892
  24. Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some properties.
    Biochem J. 1989 May 15;260(1):69-74 PMID: 2775195
  25. Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin.
    Neuropediatrics. 2002 Aug;33(4):199-202 PMID: 12368990
  26. Phospholipids accumulation in mucolipidosis IV cultured fibroblasts.
    J Inherit Metab Dis. 1988;11(2):144-50 PMID: 3139925
  27. The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles.
    J Cell Biol. 2000 May 29;149(5):1053-62 PMID: 10831609
  28. Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein.
    Proc Natl Acad Sci U S A. 1975 Aug;72(8):2925-9 PMID: 241998
  29. Cation channel activity of mucolipin-1: the effect of calcium.
    Pflugers Arch. 2005 Oct;451(1):304-12 PMID: 16133264
  30. Endocytic recycling.
    Nat Rev Mol Cell Biol. 2004 Feb;5(2):121-32 PMID: 15040445
  31. TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity.
    J Biol Chem. 2006 Mar 17;281(11):7294-301 PMID: 16361256
  32. In vitro incorporation of radiolabeled cholesteryl esters into high and low density lipoproteins.
    J Lipid Res. 1989 Nov;30(11):1663-71 PMID: 2693568
  33. Activating mutation in a mucolipin transient receptor potential channel leads to melanocyte loss in varitint-waddler mice.
    Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18321-6 PMID: 17989217
  34. Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel.
    Hum Mol Genet. 2004 Mar 15;13(6):617-27 PMID: 14749347
  35. Elevated lysosomal pH in Mucolipidosis type IV cells.
    Clin Chim Acta. 1999 Feb;280(1-2):173-9 PMID: 10090534
  36. Endocytosis.
    Physiol Rev. 1997 Jul;77(3):759-803 PMID: 9234965
  37. Lysosomal inclusions in gastric parietal cells in mucolipidosis type IV: a novel cause of achlorhydria and hypergastrinemia.
    Am J Surg Pathol. 1999 Dec;23(12):1527-31 PMID: 10584706
  38. Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs).
    Eur J Biochem. 2001 Nov;268(22):5851-6 PMID: 11722572
  39. Physiological functions of CLC Cl- channels gleaned from human genetic disease and mouse models.
    Annu Rev Physiol. 2005;67:779-807 PMID: 15709978
  40. Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway.
    FEBS Lett. 2002 Dec 4;532(1-2):183-7 PMID: 12459486
  41. Lysosomes: fusion and function.
    Nat Rev Mol Cell Biol. 2007 Aug;8(8):622-32 PMID: 17637737
  42. Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis.
    J Inherit Metab Dis. 2001 Oct;24(5):577-86 PMID: 11757585
  43. Mechanisms for cellular cholesterol transport: defects and human disease.
    Physiol Rev. 2006 Oct;86(4):1237-61 PMID: 17015489
  44. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity.
    Nat Cell Biol. 2006 Sep;8(9):933-44 PMID: 16921366
  45. Acidification and protein traffic.
    Int Rev Cytol. 2003;226:259-319 PMID: 12921239
  46. The molecular basis of mucolipidosis type IV.
    Curr Mol Med. 2002 Aug;2(5):445-50 PMID: 12125810
  47. Characterization of intracellular pH gradients in human multidrug-resistant tumor cells by means of scanning microspectrofluorometry and dual-emission-ratio probes.
    Int J Cancer. 1999 Mar 31;81(1):81-9 PMID: 10077157
  48. Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV.
    Am J Hum Genet. 2000 Nov;67(5):1110-20 PMID: 11013137
  49. Mucolipidosis type IV: abnormal transport of lipids to lysosomes.
    J Inherit Metab Dis. 1997 Sep;20(5):625-32 PMID: 9323557
  50. Posttranslational cleavage and adaptor protein complex-dependent trafficking of mucolipin-1.
    J Biol Chem. 2006 May 5;281(18):12751-9 PMID: 16517607
  51. Membrane dynamics and the biogenesis of lysosomes.
    Mol Membr Biol. 2003 Apr-Jun;20(2):141-54 PMID: 12851071
  52. Mitochondrial aberrations in mucolipidosis Type IV.
    J Biol Chem. 2006 Dec 22;281(51):39041-50 PMID: 17056595
  53. Role of cholesterol and lipid organization in disease.
    Nature. 2005 Dec 1;438(7068):612-21 PMID: 16319881
  54. Mucolipidosis type IV: ganglioside sialidase deficiency.
    Biochem Biophys Res Commun. 1979 Oct 29;90(4):1341-7 PMID: 518603
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
1540-9538
Published
2008-06-09
Epub
2008-00-26
Pages
1477-90
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2413042
Subset
IM
Grants
NIDDK NIH HHS · R01 DK054407 · United States
NCRR NIH HHS · TL1 RR024155 · United States
NIDDK NIH HHS · DK54407 · United States
NCRR NIH HHS · 5TL1RR024155-02 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]